{"id":"https://genegraph.clinicalgenome.org/r/3ac4b2f9-552a-4a34-8981-da374769b056v1.0","type":"EvidenceStrengthAssertion","dc:description":"*CTR9* was first reported in relation to autosomal dominant *CTR9*-related neurodevelopmental disorder in 2022 (Meuwissen et al., PMID: 35499524; Suzuki et al., PMID: 35717577). *CTR9* encodes a member of the polymerase-associated factor 1 (PAF1) protein complex, which associates with RNA polymerase II and a histone methyltransferase complex, and plays critical roles in transcriptional elongation and transcription-coupled histone modifications.\n\nSeventeen unique missense variants reported in 20 probands in 6 publications (PMIDs: 25363760, 33057194, 35499524, 35717577, 35982159, 35982160) are included in this curation. Most reported variants are *de novo*, although one patient was reported who inherited the variant from his mildly affected father (PMID: 35499524). Two variants were identified as recurrent: p.Pro25Arg in 2 patients and p.Glu376Lys in 3 patients. Most of the curated variants lacked supportive functional evidence. The mechanism of disease is suggested to be dominant negative (PMID: 35717577), but more functional studies are needed. Patients with *de novo* truncating variants have also been reported in large autism or developmental disorder cohorts (PMIDs: 33057194, 35982159), but were not scored in this curation due to the unclear contribution of these variants to the neurodevelopmental phenotype. There are also reports of patients with Wilms tumor who have inherited germline *CTR9* truncating variants but do not exhibit a neurodevelopmental phenotype (PMIDs: 25099282, 29292210), and myeloid malignancy patients with inherited *CTR9* missense variants that demonstrate partial loss of function (PMID: 38218188); these gene-disease associations will be curated separately as they have a different phenotype and disease mechanism. *CTR9* is highly constrained for both missense (Z = 4.8, gnomAD v4.1.0) and loss-of-function variants (pLI = 1).\n\nThere are a limited number of probands with detailed phenotypic features reported (PMIDs: 35499524, 35717577). Of those cases, affected individuals present with varying degrees of intellectual disability, motor and speech delay, hypotonia, and behavioral abnormalities including autism spectrum disorder. Cardiac anomalies, mild facial dysmorphism, and macrocephaly occurred less frequently.\n\nThis gene-disease relationship is also supported by biochemical function, protein interaction and a zebrafish model (PMIDs: 35713103, 15632063, 20541477, 35717577). Other genes with histone methyltransferase activity (e.g., *NSD1*, *EHMT1*, *SETD2*) are also associated with neurodevelopmental disorders. The PAF1 complex interacts with the RNA polymerase II subunit POLR2A and the histone methyltransferase KMT2A, both of which are involved in neurodevelopmental disorders.\n\nIn summary, there is moderate evidence supporting the relationship between *CTR9* and autosomal dominant *CTR9*-related neurodevelopmental disorder. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on March 19, 2025 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3ac4b2f9-552a-4a34-8981-da374769b056","GCISnapshot":"https://genegraph.clinicalgenome.org/r/d392f595-9554-4bf9-8dfa-2baa71280565","calculatedEvidenceStrength":"Moderate","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/d392f595-9554-4bf9-8dfa-2baa71280565_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-03-19T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/d392f595-9554-4bf9-8dfa-2baa71280565_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-05-22T15:49:07.083Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d392f595-9554-4bf9-8dfa-2baa71280565_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b34d74d-500e-48ab-9715-6dfda99450dc","type":"EvidenceLine","dc:description":"This variant was identified in 1/1613794 alleles (freq: 6.197e-7) in gnomAD v4.1.0. Although there is no functional evidence of pathogenicity for this missense variant, the default score was not downgraded because this variant is recurrent (identified in 3 unrelated patients).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b34d74d-500e-48ab-9715-6dfda99450dc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"H3K4/H3K36 methylation analysis, mitochondrial quality assessment, and RNA-seq was performed in fibroblasts from a patient with the same c.1126G>A (p.Glu376Lys) CTR9 variant; no conclusive evidence for downstream functional effects was identified from these functional assays.","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/5b34d74d-500e-48ab-9715-6dfda99450dc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35499524","allele":{"id":"https://genegraph.clinicalgenome.org/r/f06d22fa-b28c-4771-a07f-c4ee8bb22fc5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.1126G>A (p.Glu376Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA354950"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2114a85d-aa15-4124-b1d4-d4c1ad7f45ca","type":"EvidenceLine","dc:description":"Protein truncating variants have also been reported in Wilms tumor patients who do not have a neurodevelopmental phenotype, therefore the role of predicted null variants is unclear and are not counted in this curation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2114a85d-aa15-4124-b1d4-d4c1ad7f45ca_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33057194","allele":{"id":"https://genegraph.clinicalgenome.org/r/3984ff1e-eb84-4fcc-a5b3-0f2891635131","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.1473C>G (p.Tyr491Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379667961"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/e58a896d-96fc-4b0c-a158-ad344651a716","type":"EvidenceLine","dc:description":"This variant was identified in 1/1614104 alleles (freq: 6.195e-7) in gnomAD v4.1.0.\nThe default score was downgraded because the missense variant has no functional evidence of pathogenicity. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e58a896d-96fc-4b0c-a158-ad344651a716_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"H3K4/H3K36 methylation analysis, mitochondrial quality assessment, and RNA-seq was performed in fibroblasts from this patient; no conclusive evidence for downstream functional effects was identified from these functional assays.","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/e58a896d-96fc-4b0c-a158-ad344651a716_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35499524","allele":{"id":"https://genegraph.clinicalgenome.org/r/c99b1372-5fa7-4306-94b2-e98747aae385","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.254G>A (p.Cys85Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379659216"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1accf40c-2917-4495-9130-93bd7ed3c96f","type":"EvidenceLine","dc:description":"The default score was downgraded because the missense variant has no functional evidence of pathogenicity. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1accf40c-2917-4495-9130-93bd7ed3c96f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35499524","allele":{"id":"https://genegraph.clinicalgenome.org/r/df23d988-6d9c-4add-81c2-e3c801a79c5f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.109G>C (p.Glu37Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379675187"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e10c594c-5a03-42a1-8a18-2bfb4e1ccbd7","type":"EvidenceLine","dc:description":"This variant was identified in 1/1612464 alleles (freq: 6.202e-7) in gnomAD v4.1.0.\nThe default score was downgraded because the missense variant has no functional evidence of pathogenicity. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e10c594c-5a03-42a1-8a18-2bfb4e1ccbd7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35499524","allele":{"id":"https://genegraph.clinicalgenome.org/r/d1ec8516-819b-4cd0-b227-472f181e8396","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.2633G>A (p.Arg878Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379676372"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1cdf3a8e-02de-4266-bb73-c38442254d31","type":"EvidenceLine","dc:description":"The default score was downgraded because the missense variant has no functional evidence of pathogenicity. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1cdf3a8e-02de-4266-bb73-c38442254d31_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33057194","allele":{"id":"https://genegraph.clinicalgenome.org/r/b5386a98-e8b1-4fcc-8dbf-31aa4bf35456","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.953T>C (p.Val318Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379664142"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/4b187934-6ea7-4069-8176-354f206bd1b3","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b187934-6ea7-4069-8176-354f206bd1b3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35499524","allele":{"id":"https://genegraph.clinicalgenome.org/r/fcf3aef8-0898-4c42-9a53-a4e8c5208912","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.2296A>G (p.Thr766Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379675222"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/b839e84c-b0a8-4907-8f0f-bea1d9eec7a3","type":"EvidenceLine","dc:description":"This variant was identified in 7/1614182 alleles (freq: 0.000004337) in gnomAD v4.1.0, therefore it is unclear if it would contribute to disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b839e84c-b0a8-4907-8f0f-bea1d9eec7a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35499524","allele":{"id":"https://genegraph.clinicalgenome.org/r/3c5759e9-f1a3-40a0-8f70-e20d74d7d478","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.1364A>G (p.Asn455Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5885073"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f35cb85b-fb6b-45b8-a398-e1e9a6f46a9f","type":"EvidenceLine","dc:description":"The default score was downgraded because the missense variant has no functional evidence of pathogenicity. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f35cb85b-fb6b-45b8-a398-e1e9a6f46a9f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35982160","allele":{"id":"https://genegraph.clinicalgenome.org/r/0e752a59-09a3-40c2-a1cc-3e497c868b43","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.116C>G (p.Thr39Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379675223"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/eebe83e3-46dc-4b28-a0a5-23a03ff8baf6","type":"EvidenceLine","dc:description":"Protein truncating variants have also been reported in Wilms tumor patients who do not have a neurodevelopmental phenotype, therefore the role of predicted null variants is unclear and are not counted in this curation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eebe83e3-46dc-4b28-a0a5-23a03ff8baf6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33057194","allele":{"id":"https://genegraph.clinicalgenome.org/r/02b8df24-684d-4263-a2f0-3648a822d22c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.46-2A>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379674890"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/196c2b5e-70c3-422a-b257-b22c18dc6521","type":"EvidenceLine","dc:description":"The default score was downgraded because the missense variant has no functional evidence of pathogenicity. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/196c2b5e-70c3-422a-b257-b22c18dc6521_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25363760","allele":{"id":"https://genegraph.clinicalgenome.org/r/bb07d8cb-bb0e-4cf8-8c0f-81da9c1f425c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.2488C>T (p.Arg830Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379676027"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a982f095-ba0a-471b-a711-8a1c04d4aca5","type":"EvidenceLine","dc:description":"This variant was identified in 11/1610888 (freq: 0.000006829) alleles in gnomAD v4.1.0, therefore it is unclear if it would contribute to disease.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a982f095-ba0a-471b-a711-8a1c04d4aca5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33057194","allele":{"id":"https://genegraph.clinicalgenome.org/r/64baafd8-dbde-4125-997f-0833aa71b01a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.2524C>T (p.Arg842Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5885347"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f5594528-5f40-4687-9de7-89ea0eb568dc","type":"EvidenceLine","dc:description":"This variant is recurrent (identified in 2 unrelated patients).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f5594528-5f40-4687-9de7-89ea0eb568dc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis of this patient's variant in HEK293 cells demonstrated increased affinity for PAF1 protein/enhanced the binding of CTR9 to PAF1 compared to wildtype.\nH3K4/H3K36 methylation analysis, mitochondrial quality assessment, and RNA-seq was performed in fibroblasts from another patient with this variant but no conclusive evidence for downstream functional effects was identified from these functional assays.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/f5594528-5f40-4687-9de7-89ea0eb568dc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35717577","allele":{"id":"https://genegraph.clinicalgenome.org/r/d4755a23-1318-4f0d-a83f-be094553814f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.74C>G (p.Pro25Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379675027"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e496cc4b-3823-473d-92e0-bc3cf09d1a51","type":"EvidenceLine","dc:description":"This variant is recurrent (identified in 2 unrelated patients).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e496cc4b-3823-473d-92e0-bc3cf09d1a51_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"H3K4/H3K36 methylation analysis, mitochondrial quality assessment, and RNA-seq was performed in fibroblasts from this patient; no conclusive evidence for downstream functional effects was identified from these functional assays.\nHowever, functional analysis of another patient with the c.74C>G p.Pro25Arg variant in HEK293 cells demonstrated increased affinity for PAF1 protein/enhanced the binding of CTR9 to PAF1 compared to wildtype. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e496cc4b-3823-473d-92e0-bc3cf09d1a51_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35499524","allele":{"id":"https://genegraph.clinicalgenome.org/r/d4755a23-1318-4f0d-a83f-be094553814f"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/593cab10-2b16-4bbc-9523-1820d53e7a00","type":"EvidenceLine","dc:description":"The default score was downgraded because the missense variant has no functional evidence of pathogenicity. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/593cab10-2b16-4bbc-9523-1820d53e7a00_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35499524","allele":{"id":"https://genegraph.clinicalgenome.org/r/6d60125b-ac47-4edf-9521-5c17db637edd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.76G>C (p.Glu26Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379675032"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/d660b881-cee8-4034-ac4e-1bb24bbf149a","type":"EvidenceLine","dc:description":"This variant was identified in 1/1613794 alleles (freq: 6.197e-7) in gnomAD v4.1.0. Although there is no functional evidence of pathogenicity for this missense variant, the default score was not downgraded because this variant is recurrent (identified in 3 unrelated patients).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d660b881-cee8-4034-ac4e-1bb24bbf149a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"H3K4/H3K36 methylation analysis, mitochondrial quality assessment, and RNA-seq was performed in fibroblasts from a patient with the same c.1126G>A (p.Glu376Lys) CTR9 variant; no conclusive evidence for downstream functional effects was identified from these functional assays.","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/d660b881-cee8-4034-ac4e-1bb24bbf149a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35499524","allele":{"id":"https://genegraph.clinicalgenome.org/r/f06d22fa-b28c-4771-a07f-c4ee8bb22fc5"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d7d6f34b-7ec6-4ce7-bbba-c239c2cf4640","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d7d6f34b-7ec6-4ce7-bbba-c239c2cf4640_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"H3K4/H3K36 methylation analysis, mitochondrial quality assessment, and RNA-seq was performed in fibroblasts from this patient; no conclusive evidence for downstream functional effects was identified from these functional assays.\nHowever, functional analysis of another patient with a c.45G>C (p.Glu15Asp) variant was performed in HEK293 cells and demonstrated increased affinity for PAF1 protein/enhanced the binding of CTR9 to PAF1 with patient variants compared to wildtype.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d7d6f34b-7ec6-4ce7-bbba-c239c2cf4640_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35499524","allele":{"id":"https://genegraph.clinicalgenome.org/r/4534e230-b4e4-4595-83f2-c6bd61ae5b04","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.43G>A (p.Glu15Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379674821"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f2a4611c-722e-4f2e-ad8f-71ef7f8cc168","type":"EvidenceLine","dc:description":"The default score was downgraded because the missense variant has no functional evidence of pathogenicity. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f2a4611c-722e-4f2e-ad8f-71ef7f8cc168_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35982159","allele":{"id":"https://genegraph.clinicalgenome.org/r/124b333c-6d81-4d25-a8b9-776ceef444db","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.2273C>T (p.Ala758Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379675119"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/29bfb3d9-9a57-4466-974c-751b332a54aa","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/29bfb3d9-9a57-4466-974c-751b332a54aa_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis of this patient's missense variant in HEK293 cells demonstrated increased affinity for PAF1 protein/enhanced the binding of CTR9 to PAF1 with patient variants compared to wildtype.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/29bfb3d9-9a57-4466-974c-751b332a54aa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35717577","allele":{"id":"https://genegraph.clinicalgenome.org/r/cc2c70a0-886b-4253-8566-fcb7719a3b01","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.45G>C (p.Glu15Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379674838"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4434b43d-7ac4-47c7-8107-e26f60514333","type":"EvidenceLine","dc:description":"The default score was downgraded because the missense variant has no functional evidence of pathogenicity. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4434b43d-7ac4-47c7-8107-e26f60514333_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33057194","allele":{"id":"https://genegraph.clinicalgenome.org/r/9e6b8548-2745-456b-bc3c-7ceb921bf550","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.652C>T (p.Arg218Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379662516"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/93730180-b67b-4f9c-a777-4ca5937fb3be","type":"EvidenceLine","dc:description":"This individual also has a de novo missense variant in the SLC2A1 gene that is classified as pathogenic/likely pathogenic in Clinvar: NM_006516.4(SLC2A1):c.971C>T (p.Ser324Leu). Given the lack of phenotype information and functional evidence of pathogenicity, the significance of the CTR9 de novo variant is unclear.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/93730180-b67b-4f9c-a777-4ca5937fb3be_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33057194","allele":{"id":"https://genegraph.clinicalgenome.org/r/2e153bdd-0a97-4997-9b77-a75a882b9359","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.1514G>A (p.Arg505Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379668345"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/aba58a6b-0a75-415c-a0fe-5f2a30dc9731","type":"EvidenceLine","dc:description":"This variant was identified in 2/1613578 alleles (freq: 0.000001239) in gnomAD v4.1.0. \nThe default score was downgraded because the missense variant has no functional evidence of pathogenicity. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aba58a6b-0a75-415c-a0fe-5f2a30dc9731_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35499524","allele":{"id":"https://genegraph.clinicalgenome.org/r/fbc96370-9155-4ab3-aa14-9c40a573d67d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.1405G>A (p.Glu469Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379667241"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/892ae507-9eb5-4952-a32e-130eecde77f6","type":"EvidenceLine","dc:description":"The default score was downgraded because the missense variant has no functional evidence of pathogenicity. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/892ae507-9eb5-4952-a32e-130eecde77f6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33057194","allele":{"id":"https://genegraph.clinicalgenome.org/r/803a1756-8572-45c7-a1c3-20095ab61552","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.2515C>T (p.Arg839Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5885343"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/ac583f24-df1b-497b-a5b1-de2048d989f7","type":"EvidenceLine","dc:description":"This variant was identified in 1/1613794 alleles (freq: 6.197e-7) in gnomAD v4.1.0. Although there is no functional evidence of pathogenicity for this missense variant, the default score was not downgraded because this variant is recurrent (identified in 3 unrelated patients).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac583f24-df1b-497b-a5b1-de2048d989f7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"H3K4/H3K36 methylation analysis, mitochondrial quality assessment, and RNA-seq was performed in fibroblasts from this patient; no conclusive evidence for downstream functional effects was identified from these functional assays.","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/ac583f24-df1b-497b-a5b1-de2048d989f7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35499524","allele":{"id":"https://genegraph.clinicalgenome.org/r/f06d22fa-b28c-4771-a07f-c4ee8bb22fc5"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c590a929-22dd-4f33-bb10-1277daf48587","type":"EvidenceLine","dc:description":"Variant inherited from mildly affected father","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c590a929-22dd-4f33-bb10-1277daf48587_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35499524","allele":{"id":"https://genegraph.clinicalgenome.org/r/beebbf5b-f7f5-4f7c-ab68-5bcc67d0012c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_014633.5(CTR9):c.50T>C (p.Ile17Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA379674920"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":6.8},{"id":"https://genegraph.clinicalgenome.org/r/d392f595-9554-4bf9-8dfa-2baa71280565_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d392f595-9554-4bf9-8dfa-2baa71280565_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6fabeb74-c86f-4261-b23b-bb664c0d9d73","type":"EvidenceLine","dc:description":"Downgraded from 2 points given that the model system is a non-mammalian organism and the observed phenotype in the zebrafish is non-specific","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5efb6713-7e4a-4df8-bbc4-3050305858b4","type":"Finding","dc:description":"Zebrafish larvae injected with hCTR9-E15D or P25R mRNA exhibited forebrain swelling; zebrafish larvae injected with hCTR9-WT did not exhibit an effect on gross morphology. The phenotype in the zebrafish is non-specific but demonstrates a nervous system abnormality with overexpression of CTR9 with patient variants, which is consistent with nervous system abnormality that is found in patients. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35717577","rdfs:label":"Zebrafish model w. overexpression of Patient CTR9 variants","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ece8c99b-618f-4fa0-9800-870a138c9aa1","type":"EvidenceLine","dc:description":"Downgraded given that this evidence demonstrates an altered function for patient variants (due to the lack of rescue), but the knockout model that is rescued is not the expected mechanism of disease in humans and the model is a non-mammalian organism","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44dd5b43-7079-4705-be43-06c7da2d728f","type":"Finding","dc:description":"ctr9-KO zebrafish model exhibited cardiac edema and tended to be shorter than the wild-type at the 5 day post-fertilization (5 dpf) stage. Injection with human wild-type CTR9 (hCTR9) mRNA restored the body length shortening and heart defect in theÂ ctr9-KO zebrafish larvae; however, injection of hCTR9 with patient variants (hCTR9-E15D or P25R mRNA) did not exhibit any rescue effects\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35717577","rdfs:label":"Lack of rescue w. patient CTR9 variants in zebrafish CTR9 KO","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/d392f595-9554-4bf9-8dfa-2baa71280565_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a320b416-cd95-4d9b-9fcc-24a55f3789b3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe90e327-7aab-47c8-ae2c-85bdcd281920","type":"Finding","dc:description":"CTR9 encodes a member of the PAF1 protein complex that impacts histone methyltransferase activity; numerous other histone methyltransferase genes are associated with intellectual disability (eg. NSD1 and Sotos syndrome, SETD2 and Luscan-Lumish syndrome, EHMT1 and Kleefstra syndrome)","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35713103","rdfs:label":"Histone methyltransferase activity","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2ecac75e-4c15-4862-9fda-e9861376fcdf","type":"EvidenceLine","dc:description":"The interactions with POLR2A and KMT2A were given a score of 0.25 each, for a total protein interaction score of 0.5 points.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05b93474-8bc0-41e2-b82a-f530cfa091ad","type":"Finding","dc:description":"CTR9 is part of the PAF1 complex which binds to RNA polymerase II subunit POLR2A; POLR2A is associated with an autosomal dominant neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities (MIM: 180660)\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15632063","rdfs:label":"PAF1 complex interaction with POLR2A","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/9325ea5d-8dd5-403e-a3f2-0816757e8150","type":"EvidenceLine","dc:description":"The interactions with POLR2A and KMT2A were given a score of 0.25 each, for a total protein interaction score of 0.5 points.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f969bfea-5eb5-43d7-a2b8-1971bb9b1433","type":"Finding","dc:description":"CTR9 is part of the PAF1 complex which binds to histone methyltransferase KMT2A (also known as MLL), which is involved in Wiedemann-Steiner syndrome (MIM: 605130) and is associated with intellectual disability and ASD","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20541477","rdfs:label":"PAF1 complex interaction with KMT2A (MLL)","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Moderate","sequence":10461,"specifiedBy":"GeneValidityCriteria11","strengthScore":8.8,"subject":{"id":"https://genegraph.clinicalgenome.org/r/8j8HaZFgQXE","type":"GeneValidityProposition","disease":"obo:MONDO_1040006","gene":"hgnc:16850","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_d392f595-9554-4bf9-8dfa-2baa71280565-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}